Praesidia Biologics develops a platform to maximize the therapeutic potential of drugs.
Praesidia Biologics has raised $4.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2021.
Praesidia Biologics is headquartered in Arlington, United States.
Praesidia Biologics develops a platform to maximize the therapeutic potential of drugs.
Praesidia Biologics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Praesidia Biologics — Funding & Investors." VCBacked, August 12, 2021, https://www.vcbacked.co/company/praesidia-biologics. Accessed August 14, 2026.
VCBacked. (2021). Praesidia Biologics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/praesidia-biologics
{{cite web |title=Praesidia Biologics — Funding & Investors |url=https://www.vcbacked.co/company/praesidia-biologics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated